Victoza vs. Contrave: Uses, Side Effects and Dosing

See how Victoza and Contrave compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • For type 2 diabetes, Victoza is the closer fit: it's FDA-approved for blood sugar control and to lower cardiovascular risk, not for weight loss. Saxenda, a higher liraglutide dose, holds that approval.

  • For weight management, Contrave is the closer fit: it's FDA-approved specifically for chronic weight management and is taken as a twice-daily pill, reaching the full dose in week 4.

  • Victoza is a once-daily injection while Contrave is swallowed, and each carries its own boxed warning: thyroid tumor risk for Victoza, suicidal thoughts and behavior risk for Contrave.

Victoza vs. Contrave at a Glance

Victoza

At a glance
At a Glance
FEATURE VICTOZA
Drug class GLP-1 receptor agonist (liraglutide)
Form Once-daily injection
Approved use Type 2 diabetes (ages 10 and up); lowering heart risk in adults with type 2 diabetes and heart disease
Boxed warning Thyroid C-cell tumors (seen in animal studies)
Generic available Yes, generic liraglutide

Contrave

At a glance
At a Glance
FEATURE CONTRAVE
Drug class Naltrexone and bupropion combination
Form Extended-release tablet, twice daily at full dose
Approved use Chronic weight management in adults
Boxed warning Suicidal thoughts and behaviors (bupropion)
Generic available Check current availability with your pharmacy

Victoza vs. Contrave: How They Differ

Victoza

Victoza (liraglutide) is a GLP-1 receptor agonist approved to improve blood sugar control in adults and children 10 and older with type 2 diabetes and to lower cardiovascular risk in adults with type 2 diabetes and existing heart disease. It's given as a once-daily subcutaneous injection, with the dose increased over the first few weeks. It is not FDA-approved for weight loss; a higher-dose version, Saxenda, is used for that purpose. Generic liraglutide has been available since 2024 and usually costs less than the brand.

The Victoza (liraglutide) medication guide covers each dose step, and generic vs brand liraglutide explains how the two compare.

Contrave

Contrave combines naltrexone, an opioid antagonist, with bupropion, an antidepressant, and is approved specifically for chronic weight management in adults with obesity or overweight plus a weight-related condition. It's taken as an extended-release tablet, with the dose increased by one tablet each week, reaching the twice-daily maintenance dose by week 4. Unlike Victoza, it is not used to treat diabetes or reduce cardiovascular risk.

What Victoza and Contrave Are Approved For

Victoza

Victoza is approved to help control blood sugar in adults and children 10 and older with type 2 diabetes, and to lower the risk of heart attack, stroke, or cardiovascular death in adults with type 2 diabetes and existing heart disease. It is not approved for weight loss, though liraglutide at a higher dose is sold separately as Saxenda for that purpose. Using Victoza specifically to lose weight is an off-label use.

  • Adjunct to diet and exercise for glycemic control in adults and children 10+ with type 2 diabetes

  • Reduces risk of major cardiovascular events in adults with type 2 diabetes and heart disease

  • Not approved for weight loss; Saxenda (higher-dose liraglutide) holds that approval

  • Not approved for type 1 diabetes

Contrave

Contrave is approved for chronic weight management in adults with obesity, or who are overweight with at least one weight-related condition such as high blood pressure or type 2 diabetes. It's meant to be used alongside a reduced-calorie diet and increased physical activity. It is not approved to treat depression, aid smoking cessation, or for use in children.

  • Approved for chronic weight management in adults with obesity, or overweight with a weight-related condition

  • Used alongside a reduced-calorie diet and increased physical activity

  • Not approved for major depressive disorder or other psychiatric conditions

  • Not approved for smoking cessation or pediatric use

Victoza vs. Contrave Side Effects

Victoza

Most common
Nausea (up to 20%)
Diarrhea (up to 12%)
Decreased appetite (up to 10%)
Vomiting (up to 9%)

Contrave

Most common
Vomiting (up to 10.7%)
Nausea (up to 32.5%)
Constipation (up to 19.2%)
Headache (up to 17.6%)

Victoza vs. Contrave Dosage

Victoza

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.6 mg once daily Week 1
Maximum dose 1.8 mg once daily After at least 1 more week, if needed
Dose changes Up to 2 increases At least 1 week apart

Contrave

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 8 mg/90 mg once daily Week 1
Maximum dose 16 mg/180 mg twice daily (2 tablets twice daily, 32 mg/360 mg per day) Week 4 onward
Dose changes 3 increases Every week

Victoza vs. Contrave Pros, Cons and Cost

Victoza

Victoza has more than a decade of real-world use and is one of the few diabetes drugs proven to reduce cardiovascular events, but it requires a daily injection and carries a boxed warning for thyroid tumor risk seen in animal studies. Your price depends on insurance, savings cards and self-pay programs; check current pricing with your pharmacy. Any use for weight loss on its own would be off-label.

Pros

  • FDA-approved to reduce cardiovascular risk in type 2 diabetes, not just control blood sugar

  • Over a decade of clinical use since 2010

  • Approved for pediatric type 2 diabetes patients 10 and older

  • No boxed warning related to psychiatric side effects

  • Generic liraglutide is available and usually costs less than the brand

Cons

  • Requires a daily injection rather than a pill

  • Boxed warning for thyroid C-cell tumor risk seen in animal studies

  • Not FDA-approved for weight loss; that use is off-label

  • High brand list price without insurance

Contrave

Contrave is an oral non-GLP-1 option approved for chronic weight management, which appeals to people who want to avoid injections. Qsymia (phentermine and topiramate) is another oral combination. Contrave carries a boxed warning for suicidal thoughts tied to its bupropion component. It has several contraindications, including seizure history and opioid use. It does not address blood sugar control or cardiovascular risk.

Avoiding injections no longer means avoiding GLP-1s: the Wegovy pill (oral semaglutide 25 mg, approved December 22, 2025) and Foundayo (orforglipron, approved April 1, 2026) are daily GLP-1 pills for weight management.

Pros

  • Oral tablet, no injections needed

  • Oral non-GLP-1 option approved for chronic weight management

Cons

  • Boxed warning for suicidal thoughts and behavior from the bupropion component

  • Twice-daily dosing after the initial titration period

  • Contraindicated with seizure history, uncontrolled hypertension, and opioid use

  • Not approved for diabetes management or cardiovascular risk reduction

  • Price varies with insurance and savings programs

Frequently Asked Questions

Weight loss

Which helps more with weight loss, Victoza or Contrave?

Contrave is the one approved for weight loss; Victoza treats type 2 diabetes, and any weight loss on it is a side effect. If weight is the goal, Saxenda vs Contrave compares Contrave with Saxenda, the liraglutide brand approved for weight, and a licensed doctor can evaluate you online for Saxenda: see get Saxenda online. Switching from one medicine to another is a decision to make with a licensed doctor; Ozempic vs Contrave compares another diabetes GLP-1.

Taking them together

Can you take Victoza and Contrave together?

Only if a licensed doctor decides it's right for you: they aren't FDA-approved for use together, there's little research on pairing them, and both can cause nausea and vomiting. If you have type 2 diabetes, get Victoza online explains how a licensed doctor can evaluate you for Victoza.

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.

Compare Victoza and Contrave

Chat Now